ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Afzelin protects against doxorubicin-induced cardiotoxicity by promoting the AMPKα/SIRT1 signaling pathway

Sun, Yixin; Guo, Danyang; Yue, Saiding; Zhou, Mingyan; Wang, Dongxu; Chen, Fengjiao; Wang, Lingling*哈尔滨医科大学; 6
Toxicology and Applied Pharmacology2023-10-15DOI: 10.1016/j.taap.2023.116687
1被引9阅读
引用收藏
分享

摘要

Background: Doxorubicin (DOX), a chemotherapeutic drug, could relieve the progressions of various diseases. However, its clinical application is limited due to its cardiotoxicity. This study aimed to investigate the effects of afzelin (a flavonol glycoside found in Houttuynia cordata) on the cardiotoxicity induced by DOX. Methods: In ex-vivo, H9C2 cells were incubated with 20, 40, or 80 mu M afzelin for 12 h, followed by the treatment with 1 mu M DOX for 12 h. In vivo, C57BL/6 J mice were intraperitoneally injected with 4 mg/kg/day DOX on days 1, 7, and 14. Meanwhile, starting from day 1, mice were intragastrically administrated with 5 mg/kg/day or 10 mg/kg/day afzelin for 20 days. The cardiac function of mice was evaluated by detecting hemodynamic parameters using the M-mode echocardiography. Results: DOX decreased the cell survival rate, and elevated apoptotic rate, as well as induced the oxidative stress and mitochondrial dysfunction in H9C2 cells. All these changes were alleviated by afzelin treatment in a concentration-dependent manner. The results were further proven by the mitigation of cardiac injury in vivo, as evidenced by the elevation of fractional shortening, heart weight/tibia length, and the rate of the increase/decrease of left ventricular pressure in mice subjected to DOX-induced cardiotoxicity. Furthermore, afzelin upregulated the expression of p-AMP-activated protein kinase alpha (AMPK alpha) and sirtuin1 (SIRT1). Dorsomorphin (an AMPK alpha inhibitor) abrogated the anti-cardiotoxicity effects of afzelin in H9C2 cells induced by DOX. Conclusion: Afzelin protected against DOX-induced cardiotoxicity by promoting the AMPK alpha/SIRT1 signaling pathway.

学科与关键词

关键词
AfzelinDoxorubicinCardiotoxicityAMPK alpha/SIRT1 signaling pathway
相关
加载中…
  • Dihydromyricetin protects against Doxorubicin-induced cardiotoxicity through activation of AMPK/mTOR pathway
    Li, Xiaoqi; Wang, Xin; Wang, Binyu; Chi, Weiqun; Li, Zhangyi; Zhang, Min; Shen, Yifu; Liu, Xu; Lu, Youmei; Liu, Yu*PHYTOMEDICINE, 2022, 99: 154027.被引 8
  • Empagliflozin attenuates doxorubicin-induced cardiotoxicity by activating AMPK/SIRT-1/PGC-1a-mediated mitochondrial biogenesis
    Chen, Meicong*2023.被引 7
  • Tubeimoside I Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating SIRT3
    Zhang, Wei; Fan, Zhixing; Wang, Fengyuan; Yin, Lin; Wu, Jinchun; Li, Dengke; Song, Siwei; Wang, Xi; Tang, Yanhong; Huang, Congxin*Oxidative Medicine and Cellular Longevity, 2023, 2023: 9966355.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
Toxicology and Applied Pharmacology
发表日期
2023-10-15
卷期
第 477 卷
页码
116687
DOI
10.1016/j.taap.2023.116687
语言
ENGLISH
成果收录
SCIE

作者

  • S

    Sun, Yixin (第一作者)

    harbin med univ

  • G

    Guo, Danyang

    6 · harbin med univ

查看全部 7 位作者收起作者
  • Y

    Yue, Saiding

  • Z

    Zhou, Mingyan

    harbin med univ

  • W

    Wang, Dongxu

    harbin med univ

  • C

    Chen, Fengjiao

    harbin med univ

  • W

    Wang, Lingling (通讯)

    6 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417